In this issue we feature:
– 2023 ESC guidelines for managing endocarditis
– 2023 ESC guidelines for ACS
– Guideline for diagnosing and managing AF
– Expert consensus statement on cardiac catheterisation for CHD
– Urgent ECMO after cardiogenic shock admission could lower mortality
– Increasing lipids with risk of worsening cardiac damage in adolescents
– New warnings of romosozumab (Evenity) CV risks
– ESC guidelines and documents planned for 2024
– Real-world incidence of severe QT prolongation in patients taking antipsychotic drugs
– Chronic hypertension and the risk of readmission for postpartum CV complications
– Utility of smartwatches for identifying arrhythmias in children
– COVID-19 resources
– Conferences, workshops and CPD